As with the 5-HT1A receptor, the 5-HT2 receptor agonists have also been suggested to reduce epileptiform activity in a penicillin epilepsy model, which was found to be counteracted (increased epileptiform activity) with a 5-HT2 receptor antagonist treatment, methysergide [30]. Here, HTR2A is linked to epilepsy.